One case had a p.Q61K mutation in KRAS, and the other had a p.A507P substitution in KIT. The former is a rare mutation that has been described in non-small-cell lung cancer and in colon cancer, with oncogenic potential. Here, KRAS is linked to non-small cell lung carcinoma.